On air · 2 of 3 networks
Centre for Human Drug Research
- chdr.nl
- Healthcare & Life Sciences
- NL
- 405 employees
Centre for Human Drug Research’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 116. Watch Centre for Human Drug Research with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 111 | Checked 30 Oct 2026 | See all 116 ads → | ||
| Meta | Not checked | — | |||
| Running | 3 | Ads on the Google Ads Transparency Center | Checked 24 Oct 2026 | Collect them with the API → |
Centre for Human Drug Research has 111 live LinkedIn ads. We recorded 3 Google ads on 24 Oct 2026.
Latest ads
- LINKEDIN · FOLLOWSince 29 Dec 2025
Get the latest jobs and industry news
- LINKEDIN · JOBSince 26 Dec 2024
- LINKEDIN · IMAGERecorded 13 Sept 2026
CHDR is your partner for Phase 1 to 1b/2a clinical trials to accelerate your research with reduced timelines. As a global leader in early-phase research, we are a one-stop shop with a full range of services, from comprehensive strategy design and data analytics for remote clients to high-quality trial execution using our validated pharmacodynamic (PD) models in our 54-bed Leiden facility. * Study Set Up: Study design, protocol writing, regulatory submission * Study Conduct: Recruitment, GMP pharmacy, study execution in our 54-bed clinical research unit, validated PD models * Analysis and Reporting: Advanced data analysis, CSR writing, FDA deliverables * Study Close Out: Regulatory close out and archiving
- LINKEDIN · IMAGERecorded 13 Sept 2026
CHDR is a global leader in early-phase clinical trials, offering proprietary pharmacodynamic (PD) models and advanced data analytics for Phase 1 to 1b/2a studies. From our Leiden facility, we provide comprehensive support for remote clients and seamless trial execution, accelerating research and reducing timelines. * Study Set Up: Study design, protocol writing, regulatory submission * Study Conduct: Recruitment, GMP pharmacy, study execution in our 54-bed clinical research unit, validated PD models * Analysis and Reporting: (advanced) data analysis, CSR writing, FDA deliverables * Study Close Out: Regulatory close out and archiving
- LINKEDIN · IMAGERecorded 13 Sept 2026
CHDR is your partner for Phase 1 to 1b/2a clinical trials to accelerate your research with reduced timelines. As a global leader in early-phase research, we are a one-stop shop with a full range of services, from comprehensive strategy design and data analytics for remote clients to high-quality trial execution using our validated pharmacodynamic (PD) models in our 54-bed Leiden facility. * Study Set Up: Study design, protocol writing, regulatory submission * Study Conduct: Recruitment, GMP pharmacy, study execution in our 54-bed clinical research unit, validated PD models * Analysis and Reporting: Advanced data analysis, CSR writing, FDA deliverables * Study Close Out: Regulatory close out and archiving
- LINKEDIN · IMAGERecorded 13 Sept 2026
CHDR is a global leader in early-phase clinical trials, offering proprietary pharmacodynamic (PD) models and advanced data analytics for Phase 1 to 1b/2a studies. From our Leiden facility, we provide comprehensive support for remote clients and seamless trial execution, accelerating research and reducing timelines. * Study Set Up: Study design, protocol writing, regulatory submission * Study Conduct: Recruitment, GMP pharmacy, study execution in our 54-bed clinical research unit, validated PD models * Analysis and Reporting: (advanced) data analysis, CSR writing, FDA deliverables * Study Close Out: Regulatory close out and archiving
6 of 116 adsSign up to see every Centre for Human Drug Research ad, filter by format and date, and get alerts on new ones.
See all 116 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.